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Single breath carbon monoxide diffusing capacity (TLCO) measurements were made
in 50 acute untreated tropical eosinophilia (TE) patients. Forty-four (38%) patients
had a low diffusing capacity (< 85% predicted) which was moderately severe (40-
70% predicted) in 22 (44%) patients. Diffusion per lire of alveolar volume (KCO)
was reduced (< 85% predicted) in 28 (56%) patients. The effective alveolar volume
(VA) was reduced (< 85% predicted) in 30 (60%) patients and there. was highly
signfiicant positive correlation between VA a d TLCO (r=0.847, P<0.001). The
reduction in TLCO, therefore, in our patients may be due to a combination of re-
duction in the area of membrane available for diffusion and to the involvement of
pulmonary capillaries, as evidenced by low VA and KCO. The reduction in TLCO in
acute TE patients may be due to acute inflammatory changes produced in the lung
parenchyma by eosinophils. However, there was no correlation between peripheral
blood eosinophils and diffusing capacity. Further studies are required to clarify
whether locally accumulated eosinophils in the lung have any relationship with
diffusing capacity.
Tropical eosinophilia (TE) is a systemic disorder involving many organs and tissues
in which the pulmonary manifestations are predominent1. The latter are characterised
by cough, dyspnoea, nocturnal wheezing and diffuse reticulonodular infiltrates on chest
radiographs, and pulmonary function tests show a combination of obstructive and rest-
rictive ventilatory defect2-10. There is associated with marked peripheral blood
eosinophilia and elevated serum concentrations of filarial specific antibodies4. The
histopathological observation of dense accumulation of eosinophils in the interstitial
tissue; which had shown considerable thickening, suggested that there was a likelihood
of diminished diffusing capacity or transfer factor in tropical eosinophilia2. A decrease
in diffusing capacity by steady state end tidal sampling method was reported by
Poh11. Because of rarity of published reports of studies on transfer factor for carbon
monoxide (TLCO) in TE, we report our findings of single breath carbon monoxide
diffusing capacity in acute tropical eosinophilia.
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As eosinophils are known to injure normal lung parenchymal cells, alveolar
epithelial cells, fibroblasts, pleural mesothelial cells and bronchial epithelial cells12-14,
it may be hypothesised that the decrease in diffusing capacity in these patients is due to
inflammatory changes produced in the interstitial tissues by the abnormal accumulation
of eosinophils and/or its toxic mediators. Since peripheral blood eosinophilia is the hall-
mark of TE, the study was also utilised to find out whether there was any relationship
between the eosinophils in the peripheral blood and single breath diffusing capacity.
Material and Methods
Fifty patients with recent onset of symptoms of one week to 6 months duration were
investigated. They fulfilled the diagnostic criteria of TE, i.e. residence in the endemic area
of Madras city, respiratory symptoms such as cough, dyspnoea and nocturnal wheezing,
chest x-ray infiltrates, peripheral blood eosinophilia of > 2000 cells/cmm, high serum
titres of antifilarial IgG and a positive response to diethyl carbamazine therapy.
Clinical evaluation of each patient included detailed history, physical examination,
chest x-ray and IgG filarial antibody determinations.
The one-second forced expiratory volume (FEV1), forced vital capacity (FVC),
FEV1/FVC per cent, total lung capacity (TLC) by helium dilution method, single breath
carbon monoxide diffusing capacity (TLCO) measurements15 were carried out
on PK Morgan (U.K.) Transnfer Test Model C using Data Dec computer.
A minimum of three consistent readings in the case of spirometry and two
in the case of TLC measurements were obtained. The highest value obtained was
used for analyses and readings were corrected to body temperature, ambient
pressure and full saturation with water vapour (BTPS). Epidemiology standardisation
project16 recommendations were followed for the measurement of single breath
diffusing capacity. The patients were seated comfortably and nose clips were
applied. The patients were instructed to exhale completely to residual volume and
on instruction to inhale a volume of test gas (Helium 14%, Carbon monoxide 0-28%,
Oxygen 18% and remainder Nitrogen) rapidly and maximally to TLC, to hold the breath
for 10 seconds and finally to exhale rapidly. The inspired volume and breath holding
time (usually between 9-11 seconds) were noted. In ail tests, the inspired volume was
adjusted to 90% of previously determined FVC. After exhalation of a preset wash out
volume of at least 700 ml, the alveolar sample was collected in an empty sample bag for
subsequent analysis. In all patients, the tests were performed in duplicate withan interval
of at least 4 minutes. The difference between the measurements was less than 5% and
the highest value was used for analysis. The effective alveolar volume (VA) corrected to
BTPS was measured by helium dilution during single breath carbon monoxide diffusing
capacity measurements15 and the transfer coefficient, i. . diffusion per litre of alveolar
volume (KCO) was calculated from the ratio of TLCO to VA.
Studies had been undertaken in 249 normal subjects, using the PK Morgan (U.K.)
Transfer Test Model C, to establish regression equations for predicting normal pul-
monary function values in regional subjects. The predicted values of VA, TLCO and KCO
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for this study are obtained from these regression-equations (unpublished data). Transfer
factor was corrected to a standard haemoglobin concentration of 14.6 G/dl, using the
following equation17.
TLCO (corrected)=TLCO (observed) x
14.6 a + Hb
(1 + a) Hb
where Hb is the actual haemoglobin concentration in G/dl and ‘a’ is 0.7. The KCO (cor-
rected) was calculated from the ratio of TLCO (corrected) to VA.
The measured values of VA, TLC O and KCO  are considered normal, if they are
within ± 15% of the predicted value18.
Results
There were 45 males and 5 females in the study, 21 males and all females were non-
smokers and 24 males were smokers. The mean age was 24.1 (SD 7.5) years (range
12-48 years) and the mean height was 160.8 (SD 7.6) cm and the mean weight 45.0
(SD 8.25) kg.The mean TLCO was 6.24±1.4 mmol/k.pa/mt (72±16% predicted
and the mean KCO was 1.88±0.25 mmol/k.pa/mt/L (83.1±12.2% predicted).
As there was no significant difference in the mean values of transfer factor and
transfer co-efficient between smokers and non-smokers, the data were pooled for
analysis.
Normal TLCO was observed only in 6 (12%) patients and 22 patients (44%) had
moderately severe diffusion defect (TLCO% predicted ranging between 40-70%). Twenty-
eight patients (56%) had a reduction in transfer co-efficient (KCO), ncluding 7 (14%)
with moderately severe reduction (Table 1).
Table 1. Severity of diffusion defect
Predicted
Observed
Observed
40.0–70.0% 70.1–85.0% >85%
TLCO 22 (4%) 6 (12%)
KCO 21 (42%) 22 (44%)
The mean haemoglobin concentration in 50 patients was 12.84±1.45 G/dl. When
the diffusing capacity was corrected to a standard haemoglobin concentration of 14-6
G/dl. Low TLCO and KCO persisted in 37 (74%) and 19 (38%) patients. respectively even
after correction of haemoglobin.
As it was observed that the effective alveolar volume (VA) was reduced (<85%
predicted) in 30 patients (60%), it was assumed that one of the mechanisms of reduced
TLCO in these patients may be due to reduction in the surface area of membrane avail-
able for diffusion. When VA was correlated with TLCO (Fig. 1), there was highly signi-
ficant positive correlation between VA and TLCO (r= 0.847, P<0.001).
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Fig. 1. Showing relationship between effective alveolar volume and transfer factor in acute tropical
eosinophilia.
Fig. 2. Showing relationship between blood absolute eosinophil count and transfer factor in acute
tropical eosinophilia.
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The absolute eosinophil count in these patients varied from 3100 to 23500 cells/
cumm and most of them (90%) had absolute eosinophil count of > 5000 cells/cumm.
As shown in Fig. 2, there was no correlation (r= – 0.164) between peripheral blood
eosinophils and transfer factor (TLCO).
Discussion
The pulmonary manifestations in acute tropical eosinophilia is inflammation of the
lung parenchyma in persons highly sensitised immunologically to filarial parasites4.
The diffusing capacity is reduced in patients with diseases of the lung parenchyma15,
and reduced diffusing capacity in TE by steady state end tidal sampling method was
reported by Poh11. Impairment of diffusion in long standing cases of TE was suggested
by Udwadia3 on the basis of histopathological evidence of dense eosinophil accumu-
lation in lung parenchyma. Our findings of reduced transfer factor by single breath
method in acute untreated tropical eosinophilia corraborates the observation that there
is alveolitis in TE.
The transfer factor is the resultant of changes in the diffusing capacity of the
alveolar capillary membrane (Dm) and the volume of blood in the alveolar capillaries
(VC) under the conditions of measurement15. Th  reduction in diffusing capacity in most
of our patients is not due to anaemia (concentration of haemoglobin range (10.1 to 15.6
G/dl). Reduction in the effective accessible gas volume (VA) and reduction in carbon
monoxide transfer per litre of effective accessible gas volume (i.e., transfer coefficient,
KCO) are the two mechanisms of reduced diffusing capacity18 and KCO provides some
indication of the density of capillaries in the wall of the alveoli. Since we have not measu-
red membrane diffusing capacity (Dm) and alveolar capillary blood volume (VC), specific
reductions regarding these parameters cannot be made.
In interstitial lung disease of various aetiologies, there is a low TLCO and KCO,
especially the membrane component, and the mechanism of this reduction is still un-
certain19. The highly significant positive correlation of TLCO with VA shows that the
reduction in transfer factor in acute TE in our patients may be mainly due to reduction
in alveolar volume. As it had been shown previously20,21 that TLCO decreases by 3%
for every 8% reduction in TLC and that alveolar surface was related to VA1/3 in the range
of 40-80% TLC, the reduction in the area of membrane available for diffusion, as evi-
denced by low VA, may be mainly responsible for low TLCO in our patients, This may
be due to acute inflammatory changes in the lung parenchyma by the abnormal accumu-
lation of eosinophils, which reduces the membrane area for diffusion. The reduction in
transfer coefficient(KCO) in 56% of our patients indirectly shows that there are changes
in pulmonary capillaries as well, as it had been shown that KCO provides some indi-
cation of the density of capillaries in the wall of the alveoli18. Our results in TE are in
agreement with the earlier morphometric studies in diffuse interstitial lung diseases22,
where it had been shown that the decreased membrane area for diffusion was the mecha-
nism for low TLCO and also that a decrease in pulmonary capillary blood volume may
be an additional contributory factor23. Our findings of high positive correlation of
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TLCO with VA, along with reductions in VA and KCO in 60% and 56% of patients suggest
that both reductions in membrane area and pulmonary capillary blood volume contri-
bute to the reduction in transfer factor in acute TE.
There was no correlation between peripheral blood eosinophils and transfer
factor (TLCO). It will be worthwhile to study whether the transfer factor is related to
the abnormally accumulated eosinophils in interstitial tissue, as shown histopathologi-
cally2. We are continuing the study on these lines utilising bronchoalveolar lavage.
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